Abstract
A recombinant enzyme-linked immunosorbent assay (ELISA) followed by a neutralization test (NT) and recombinant immunoblot assay (RIB A) were used for the detection of antibody to hepatitis C virus (anti-HCV) in 71 patients receiving 84 orthotopic liver grafts between 1984 and 1990. Before the liver transplantation (LTX) anti-HCV was present in six of the 71 recipients (8.5%) who were accepted for LTX because of acute or chronic liver failure. After LTX anti-HCV could not be detected in one of the patients, but it was continuously present in the others for more than 12 months. Detectable HCV antibodies were not present in the three patients who underwent LTX because of clinical evidence of fulminant NANB hepatitis. Two of 48 (4.2%) previously HCV seronegative recipients, who survived more than 3 months, seroconverted 9 and 16 months, respectively, after transplantation. The postoperative seroconversion was probably due to the transfer of virus via perioperative blood transfusions. Thus, these liver recipients may be able to respond by producing anti-HCV despite immunosuppressive therapy. None of the seven post-transplant HCV-seropositive patients developed symptoms such as icterus or fatigue, which would suggest the presence of liver insufficiency due to HCV infection. However, two of them had increased transaminase levels and histological signs of mild hepatitis. No significant difference was found in 1-year survival, prothrombin complex, albumin levels or the risk for retransplantation in post-transplant anti-HCV-seropositive patients, compared with those without detectable HCV antibodies (71% vs 69%, respectively). Thus, during the study period of 1–5 years, the clinical course of HCV infection was milder than that reported for hepatitis B infection in liver recipients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alter HJ (1989) Chronic consequences of non A-non B hepatitis. In: Seeff LB, Lewis JH (eds) Current perspectives in hepatology. Plenum Medical, New York, pp 83–97
Alter MJ, Coleman PJ, Alexander WJ, Kramer E, Miller JK, Mandel E, Hadler SC, Margolis HS (1989) Importance of heterosexual activity in the transmission of hepatitis B and nonA, nonB hepatitis. JAMA 262:1201–1205
Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, Kuo G (1989) Detection of antibody to hepatitis virus in prospectively followed transfusion recipients with acute and chronic nonA-nonB hepatitis. N Engl J Med 321:1494–1500
Bradley D W, Maynard JE, Popper H et al (1983) Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis 148:254–265
Brechot C, Degos F, Lugassy C et al (1985) Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 312:270–276
Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vail M, Bruguera M, Bru C, Castillo R, Rodes J (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet II: 100
Chapman RW, Forman D, Peto R, Smallwood (1990) Liver transplantation for acute hepatic failure? Lancet 1:32–35
Chiaramonte M, Ngatchu T, Stroffolini T, Rapicetta M, Chionne P, Lantum D Comparison between HBV and HCV infection in a high risk population. The British Society of Gastroenterology A262.
Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne nonA, nonB viral hepatitis genome. Science 244: 359–362
Colombo M, Kuo G, Choo QL (1989) Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet II: 1006–1008
Colombo M, Rumi MG, Donato MF, Marcelli R, De Fillippi F, Del Ninno E (1989) Hepatitis C virus infection is frequent in patients with cryptogenic cirrhosis (abstract in topic III). First International Meeting on Hepatitis C, Rome
Ericzon B-G, Eusufzai S, Kubota K, Einarsson, Angelin B (1990) Characteristics of biliary lipid metabolism after liver transplantation. Hepatology 5:1222–1228
Farci P, Alter HJ, Wong D, Miller RH, Shis JW, Jett B, Purcell RH (1991) A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 325:98–104
Fattovich G, Tagger A, Brollo L, Pontisso P, Realdi G, Ferroni P, Alberti A (1989) Liver disease in anti-HBe positive chronic HBsAg carriers and hepatitis C virus. Lancet II: 797–798
Franza A, Miguet JP, Bresson-Hadni S, Coaquette A, Lab M, Njoya O, Vanhems P, Becker MC, Rouget C, Mantion G, Gillet M (1991) Prevalence of hepatitis C virus antibodies in orthotopic liver transplantation: A sequential study of 72 patients. Transplant Proc 23:1506
Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, Parker D, Barbara JAJ, Contreras M, Aloysius S (1990) De-tecton of hepatitis C viral sequences in blood donations by ‘nested’ polymerase chain reaction and prediction of infectivity. Lancet 335:1419–1422
Grendele M, Gridelli B, Colledan M, Rossi G, Fassati LR, Ferla G, Lunghi G, Galmarini D (1989) Hepatitis C virus infection and liver transplantation. Lancet 1221–1222
Kuo G, Choo QL, Alter HJ et al (1989) An assay for circulating antibodies to a major etiological virus of human nonA, nonB hepatitis. Science 244:362–364
McFarlane I, Smith H, Johnson P, Bray G, Vergani, Williams R (1990) Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 335:754–757
Mosley JW, Redeker AG, Feinstone SM, Purcell RH (1977) Multiple hepatitis virus in multiple attacks of acute viral hepatitis. N Engl J Med 296:75–78
Potterucha JJ, Rakela J, Ludwig J, Taswell HF, Wiesner RH (1991) Hepatitis C antibodies in patients with chronic hepatitis of unknown etiology after orthotopic liver transplantation. Transplant Proc 23:1495–1497
Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL (1991) Hepatitis C in liver transplant recipients. Transplant Proc 23:1504–1505
Schwarcz R, von Sydow M, Weiland O (1991) Positive reactivity with anti-HCV ELISA in patients with autoimmune hepatitis -not confirmed with a neutralization test. Scand J Infect Dis 23: 127–128
Simonetti RG, Cottone M, Craxi A, Pagliaro L, Rapicetta M, Chionne P, Costantino A (1989) Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet II: 1338
Starzl TE, Iwatsuki S, Esquivek CO, Todo S, Kam I, Lynch S, Gordon RD, Shaw BW Jr (1985) Refinements in the surgical technique of liver transplantation. Semin Liver Dis 5:349–356
Starzl TE, Demetris DA, van Thiel D (1989) Liver transplantation. N Engl J Med 1014–1022
van der Poel CL, Cuypers HT, Reesink HW, Weiner AJ, Quan S, di Nello R, van Boven JJP, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaasberg W, Leentvaar-Kuypers A, Polito A, Houghton M, Lelie P (1991) Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 337:317–319
Yoshizawa H, Itoh Y, Iwakiri S et al (1981) Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees. Gastroenterology 81: 107–113
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Barkholt, L.M., von Sydow, M., Magnius, L., Ericzon, B.G., Veress, B., Andersson, J.P. (1992). Seroprevalence and outcome of hepatitis C in liver transplantation. In: Kootstra, G., Opelz, G., Buurman, W.A., van Hooff, J.P., MacMaster, P., Wallwork, J. (eds) Transplant International Official Journal of the European Society for Organ Transplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77423-2_56
Download citation
DOI: https://doi.org/10.1007/978-3-642-77423-2_56
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55342-7
Online ISBN: 978-3-642-77423-2
eBook Packages: Springer Book Archive